Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine.
- DOI
- 10.1016/j.vaccine.2026.129068
- Published
- 2026 Oct 24
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.129068,
title = {Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine.},
author = {Desai M and Cardona J and Khetan S and Mehta S and Kapoor A and Okparavero A and Lin Z and Priddy F},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.129068},
url = {https://doi.org/10.1016/j.vaccine.2026.129068}
}RIS
TY - JOUR TI - Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine. AU - Desai M AU - Cardona J AU - Khetan S AU - Mehta S AU - Kapoor A AU - Okparavero A AU - Lin Z AU - Priddy F PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.129068 UR - https://doi.org/10.1016/j.vaccine.2026.129068 ER -
APA
M, D., J, C., S, K., S, M., A, K., A, O., Z, L., & F, P. (2026). Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.129068
Source records
- pubmed · retrieved 2026-11-10T16:35:23.650Z